Literature DB >> 26385116

Triamterene in the Treatment of Hypertension: More Than Just Potassium Sparing?

Gerald W Smetana1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26385116      PMCID: PMC4700017          DOI: 10.1007/s11606-015-3515-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  10 in total

Review 1.  Crystal-induced acute renal failure.

Authors:  M A Perazella
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

2.  Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.

Authors:  Gerald W Smetana
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

Review 6.  Beta-blockers for hypertension.

Authors:  Charles Shey Wiysonge; Hazel A Bradley; Jimmy Volmink; Bongani M Mayosi; Anthony Mbewu; Lionel H Opie
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.

Authors:  B Pitt; R P Byington; C D Furberg; D B Hunninghake; G B Mancini; M E Miller; W Riley
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

8.  Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension.

Authors:  Wanzhu Tu; Brian S Decker; Zangdong He; Blake L Erdel; George J Eckert; Richard N Hellman; Michael D Murray; John A Oates; J Howard Pratt
Journal:  J Gen Intern Med       Date:  2016-01       Impact factor: 5.128

9.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

Review 10.  Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.

Authors:  Balraj S Heran; Jenny M H Chen; Josh J Wang; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
  10 in total
  2 in total

1.  Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity.

Authors:  Na Yeon Park; Doo Sin Jo; Yong Hwan Kim; Ji-Eun Bae; Joon Bum Kim; Hyun Jun Park; Ji Yeon Choi; Ha Jung Lee; Jeong Ho Chang; Heeyoun Bunch; Hong Bae Jeon; Yong-Keun Jung; Dong-Hyung Cho
Journal:  Arch Pharm Res       Date:  2021-06-07       Impact factor: 4.946

2.  Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals.

Authors:  Yingxiao Li; Kai Chun Cheng; Chiang-Shan Niu; Shih-Hsiang Lo; Juei-Tang Cheng; Ho-Shan Niu
Journal:  Drug Des Devel Ther       Date:  2017-04-05       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.